HealthBristol Myers blood cancer cell therapy succeeds in mid-stage trial
Bristol Myers Squibb said its experimental cell therapy produced a high overall response rate in a mid-stage trial involving patients with a difficult-to-treat form of blood cancer.
R
Reuters★★☆☆☆2026-09-08 16:35Original
Bristol Myers blood cancer cell therapy succeeds in mid-stage trial
Health